Cadre Holdings, Inc. (CDRE) Stock Price & Analysis
Cadre Holdings, Inc. (CDRE) closed at USD 29.46 on Thursday, October 22, 2026, up 6.74% on the day. The US market is currently closed (pre-market); this is not a live price.
The prior close was USD 27.6; the Oct 22, 2026 session ranged USD 27.24–29.52 on volume of 564,372 shares. Market capitalization is $1.26B, with a 52-week range of USD 24.07–48.76 (NYQ). Source: Nexqual, retrieved October 23, 2026 at 09:25 UTC.
Also available as compact Markdown for AI agents: nexqual.com/CDRE.md
Key facts (CDRE)
- Last four reported quarters (through Jun 30, 2026): revenue $686M, net income $36.1M (5.3% margin), free cash flow $78.1M (SEC filings).
- Valuation: P/E 35.0x (avg 36.2x at the last 3 fiscal year-ends), EV/EBITDA 17.4x, net debt $320M.
- Earnings quality: non-operating income -$16.8M vs operating income $69.1M over the last four quarters; P/E excluding non-operating income ≈26.5x (estimate: non-operating income taxed at the company's 31% effective rate).
- 1 of 80 tracked superinvestors hold CDRE (13F, Q2 2026): 1 new, 0 added, 0 reduced, 0 unchanged.
- Analysts: Buy (mean 1.67 on a 1–5 scale) (6 analysts), mean target USD 45.83 (range 35–62).
- Total return with dividends: 1Y -30.1% vs S&P 500 +14.9%; 5Y +104.6% vs S&P 500 +80.3%.
- Next earnings: 2026-11-04, EPS estimate USD 0.34, revenue estimate $191M.
Financials (SEC 10-K; TTM = last four 10-Q/10-K quarters) (CDRE)
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | TTM |
|---|---|---|---|---|---|---|
| Revenue | $427M | $458M | $483M | $568M | $610M | $686M |
| Gross profit | $171M | $176M | $201M | $233M | $260M | — |
| Operating income | $51.7M | $16.7M | $56.5M | $66.8M | $67.4M | $69.1M |
| Net income | $12.7M | $5.8M | $38.6M | $36.1M | $44.1M | $36.1M |
| EPS (diluted) | $0.44 | $0.16 | $1.02 | $0.90 | $1.02 | — |
| Free cash flow | $37.3M | $41.9M | $66.5M | $26.1M | $56.8M | $78.1M |
| Gross margin | 39.9% | 38.4% | 41.6% | 41.1% | 42.5% | — |
| Operating margin | 12.1% | 3.7% | 11.7% | 11.8% | 11.0% | 10.1% |
| Net margin | 3.0% | 1.3% | 8.0% | 6.4% | 7.2% | 5.3% |
| Revenue growth | +5.6% | +7.1% | +5.4% | +17.6% | +7.5% | — |
| Cash + short-term investments | $33.9M | $45.3M | $87.7M | $125M | $123M | — |
| Total debt | $160M | $150M | $140M | $223M | $307M | — |
Fiscal years end Dec. EPS is split-adjusted.
Valuation (price ÷ last four quarters, through Jun 30, 2026) (CDRE)
P/E 35.0x · P/E ex non-operating (est.) ≈26.5x · P/S 1.8x · EV/EBITDA 17.4x · EV/Sales 2.3x · P/FCF 16.1x · P/B 3.6x · FCF yield 6.19% · Earnings yield 2.86% · Dividend yield (paid, TTM) 1.29% · Net debt $320M · EV $1.58B
P/E at fiscal year-ends: Dec 2025 40.2x, Dec 2024 36.1x, Dec 2023 32.3x.
Superinvestors (SEC 13F-HR, Q2 2026) (CDRE)
1 of 80 tracked investors hold CDRE. Each row is the investor's latest 13F; change is vs their prior-quarter share count.
| Investor | Firm | % of portfolio | Value | Change |
|---|---|---|---|---|
| First Eagle Investment | First Eagle Investment Management | 0.01% | $8.7M | New position |
Analysts (CDRE)
Consensus Buy (mean 1.67 on a 1–5 scale), 6 analysts; mean target USD 45.83 (low 35, high 62).
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-10-13 | JP Morgan | Target lowered | Overweight | $45 → $35 |
| 2026-08-10 | DA Davidson | Target raised | Overweight | $40 → $43 |
| 2026-08-10 | Roth Capital | Target raised | Buy | $40 → $43 |
| 2026-08-07 | JP Morgan | Target raised | Overweight | $40 → $45 |
| 2026-07-27 | JP Morgan | Initiated | Overweight | $40 |
Total return (dividends reinvested) (CDRE)
| 1Y (from 2025-10-23) | 5Y (from 2021-11-01) | |
|---|---|---|
| Total return | -30.1% | +104.6% |
| S&P 500 (SPY) | +14.9% | +80.3% |
| Per year | -30.1% | +15.5% |
| Volatility (annualized) | 47.8% | 43.7% |
| Max drawdown | -46.4% (Mar 2026→Oct 2026) | -44.3% (Feb 2026→Oct 2026) |
CDRE analyst estimates and revisions
| Period | EPS estimate | 90 days ago | Change | Revenue estimate | Analysts |
|---|---|---|---|---|---|
| Current quarter (ends Sep 2026) | $0.34 | $0.40 | -16.0% | $190.5M | 2 |
| Next quarter (ends Dec 2026) | $0.48 | $0.53 | -9.4% | $205.5M | 2 |
| Current fiscal year (ends Dec 2026) | $1.42 | $1.34 | +6.1% | $759.4M | 2 |
| Next fiscal year (ends Dec 2027) | $1.64 | $1.34 | +22.5% | $809.0M | 2 |
Key Statistics (as of October 23, 2026 at 09:25 UTC)
| Price | USD 29.46 |
|---|---|
| Change | ▲ 6.74% (up) |
| Previous Close | USD 27.6 |
| Open | USD 27.53 |
| Day Range | USD 27.24 – 29.52 |
| 52-Week Range | USD 24.07 – 48.76 |
| Volume | 564,372 shares |
| Market Cap | $1.26B |
| Exchange | NYQ |
Technical Analysis (CDRE)
Nexqual's technical model rates CDRE "BUY" based on 5 bullish and 2 bearish signals across 127 daily candles, as of October 23, 2026 at 09:25 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 68.42 (neutral) |
| vs SMA50 | Above (USD 28.36) |
| MACD | 0 (positive) |
Analyst Ratings (CDRE)
Wall Street analysts rate CDRE "Buy" based on 6 analysts, with a mean price target of USD 45.83 (range USD 35–62), per Nexqual as of October 23, 2026 at 09:25 UTC.
| Consensus Rating | Buy |
|---|---|
| Analyst Count | 6 |
| Mean Target | USD 45.83 |
| High Target | USD 62 |
| Low Target | USD 35 |
| Buy / Hold / Sell | 6 / 0 / 0 |
Earnings (CDRE)
| Next Earnings Date | 2026-11-04 |
|---|---|
| EPS Estimate | USD 0.34 |
| Revenue Estimate | $190.53M |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-06-30 | USD 0.48 vs est 0.32 ▲ beat |
| 2026-03-31 | USD 0.18 vs est 0.09 ▲ beat |
| 2025-12-31 | USD 0.29 vs est 0.47 ▼ miss |
| 2025-09-30 | USD 0.38 vs est 0.28 ▲ beat |
Source: Nexqual, October 23, 2026 at 09:25 UTC.
Financials & Fundamentals (CDRE)
| Total Revenue | $685.65M |
|---|---|
| Revenue Growth (latest quarter, YoY) | +31.80% |
| Gross Margin | +42.65% |
| Operating Margin | +12.69% |
| Profit Margin | +5.26% |
| ROE | +10.62% |
| Debt / Equity | 1.15 |
| Current Ratio | 2.14 |
| Total Cash | $54.77M |
| Total Debt | $400.05M |
| Free Cash Flow (last four quarters to Jun 2026, SEC 10-Q / 10-K) | $78.12M (11.4% of revenue) |
Source: Nexqual, October 23, 2026 at 09:25 UTC.
Financial Health Score (CDRE)
Nexqual rates Cadre Holdings, Inc.'s overall financial health "Solid" across five dimensions, as of October 23, 2026 at 09:25 UTC.
| Growth | Solid — Revenue +8% YoY (annual) |
|---|---|
| Profitability | Strong — Gross margin 43%, operating 13% (last 12 months) |
| Balance Sheet | Mixed — $54M cash and investments vs $374M debt (Jun 2026, SEC) |
| Cash Flow | Solid — FCF $78M (last 4 quarters to Jun 2026, SEC), 11% margin |
| Efficiency | Mixed — ROE 11%, ROA 6.1% |
Ownership (CDRE)
| Insider Ownership | +27.09% |
|---|---|
| Institutional Ownership | +78.35% |
| Shares Outstanding | 42.82M |
| Float | 28.35M |
| Short % of Float | +6.44% |
Source: Nexqual, October 23, 2026 at 09:25 UTC.
Leadership (CDRE)
Cadre Holdings, Inc. is led by Warren B. Kanders, Executive Chairman & CEO, per Nexqual as of October 23, 2026 at 09:25 UTC.
| Executive Chairman & CEO | Warren B. Kanders |
|---|---|
| President | Brad E. Williams |
| Chief Financial Officer | Blaine Browers |
Major Backers & Investors (CDRE)
Notable institutional backers of Cadre Holdings, Inc. include SmallCap World Fund Inc, Greenhouse Funds, LLLP, FMR, LLC, according to Nexqual as of October 23, 2026 at 09:25 UTC.
Active Investors
| Investor | Stake |
|---|---|
| SmallCap World Fund Inc | 7.98% |
| Greenhouse Funds, LLLP | 6.7% |
| FMR, LLC | 5.78% |
| Reinhart Partners, LLC | 5.34% |
| Capital International Investors | 3.79% |
| GW&K Investment Management, LLC | 2.98% |
| Capital Group | 2.81% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| BlackRock | 6.86% |
| State Street | 4.55% |
| Vanguard Group | 3.09% |
Source: Nexqual, October 23, 2026 at 09:25 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| KTOS | Kratos Defense & Security Solut | USD 38.27 | ▼ 1.21% |
| SARO | StandardAero, Inc. | USD 21.72 | ▲ 1.26% |
| CAE | CAE Inc | USD 25.02 | ▲ 2.08% |
| DRS | Leonardo DRS, Inc. | USD 34.3 | ▲ 1.06% |
| MOG-B | Moog Inc. | USD 335.16 | ▼ 8.43% |
| HII | Huntington Ingalls Industries, | USD 278.86 | ▲ 1.79% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 23, 2026 at 09:25 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt